SIG BROKERAGE, LP
Broker-DealerPosition in GALT — Galectin Therapeutics Inc
CIK 1094429
BALA CYNWYD, PA
Position in GALT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,932
-$18,627 QoQ
Shares Held
13,596
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Derivatives in GALT
reported options exposure · as of Dec 31, 2024CallValue
$25,155
CallShares
19,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIG BROKERAGE, LP holds $10,788,089 across 9 Biotechnology names. GALT ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,605 | $7,861,336 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
20,292 | $1,702,904 | |
| 3 | CYTK |
Cytokinetics Inc
|
6,011 | $396,185 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
2,298 | $388,407 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,326 | $205,787 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
14,496 | $76,683 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
15,429 | $65,264 | |
| 8 | NMRA |
Neumora Therapeutics, Inc.
|
27,483 | $53,591 |
All Filings in GALT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,932 | 13,596 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $56,559 | 13,596 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,640 | 15,717 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,145 | 19,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,790 | 19,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,155 | 19,500 | Call | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||